Literature DB >> 2664729

Late onset of skin cancers in 2 xeroderma pigmentosum group F siblings and a review of 30 Japanese xeroderma pigmentosum patients in groups D, E and F.

S Kondo1, A Mamada, C Miyamoto, C H Keong, Y Satoh, Y Fujiwara.   

Abstract

Sib patients with xeroderma pigmentosum (XP), XP90TO (42 years old, male) and XP92TO (40 years old, female, were assigned to group F by the complementation analysis in hybridized heterodikaryons. The XP90TO and XP92TO fibroblasts exhibited the typical XPF characteristics of a threefold higher sensitivity to the lethal effect of 254 nm UV and a reduced level of 12% unscheduled DNA synthesis (UDS) compared with normal cells. Clinically, both patients manifested moderate to severe acute sun sensitivity by age 8, pigmented freckles by age 10 and skin malignancies at higher ages (6 basaliomas at 42 years in XP90TO; 1 basalioma at 41 years in XP92TO). Despite the still currently sun-sensitive state, the patients showed normal minimal erythema dose (MED) at monochromatic wavelengths of 290, 300 and 305 nm but abnormally delayed peaking of erythema reaction at 48 h after exposure. After irradiation with more than 3 MED, XP92TO showed a long persistence of induced erythema for at least 7 days. A review of the 16 reported XPF patients indicated mild skin manifestations, no neurological abnormalities, and more delayed skin carcinogenesis at a lower frequency than that in XPA patients. In addition, we have collected clinical information from Japanese XP patients in rare complementation groups D and E and reviewed their clinical and photobiological characteristics.

Entities:  

Mesh:

Year:  1989        PMID: 2664729

Source DB:  PubMed          Journal:  Photodermatol        ISSN: 0108-9684


  7 in total

1.  First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure.

Authors:  Nicolaas G J Jaspers; Anja Raams; Margherita Cirillo Silengo; Nils Wijgers; Laura J Niedernhofer; Andria Rasile Robinson; Giuseppina Giglia-Mari; Deborah Hoogstraten; Wim J Kleijer; Jan H J Hoeijmakers; Wim Vermeulen
Journal:  Am J Hum Genet       Date:  2007-01-29       Impact factor: 11.025

Review 2.  Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.

Authors:  Siobhán Q Gregg; Andria Rasile Robinson; Laura J Niedernhofer
Journal:  DNA Repair (Amst)       Date:  2011-05-25

3.  The Cerebro-oculo-facio-skeletal Syndrome Point Mutation F231L in the ERCC1 DNA Repair Protein Causes Dissociation of the ERCC1-XPF Complex.

Authors:  Maryam Faridounnia; Hans Wienk; Lidija Kovačič; Gert E Folkers; Nicolaas G J Jaspers; Robert Kaptein; Jan H J Hoeijmakers; Rolf Boelens
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

4.  Correction of the DNA repair defect in xeroderma pigmentosum group E by injection of a DNA damage-binding protein.

Authors:  S Keeney; A P Eker; T Brody; W Vermeulen; D Bootsma; J H Hoeijmakers; S Linn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  A 127 kDa component of a UV-damaged DNA-binding complex, which is defective in some xeroderma pigmentosum group E patients, is homologous to a slime mold protein.

Authors:  M Takao; M Abramic; M Moos; V R Otrin; J C Wootton; M McLenigan; A S Levine; M Protic
Journal:  Nucleic Acids Res       Date:  1993-08-25       Impact factor: 16.971

6.  USP45 deubiquitylase controls ERCC1-XPF endonuclease-mediated DNA damage responses.

Authors:  Ana B Perez-Oliva; Christophe Lachaud; Piotr Szyniarowski; Ivan Muñoz; Thomas Macartney; Ian Hickson; John Rouse; Dario R Alessi
Journal:  EMBO J       Date:  2014-12-23       Impact factor: 11.598

7.  Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect.

Authors:  Hiva Fassihi; Mieran Sethi; Heather Fawcett; Jonathan Wing; Natalie Chandler; Shehla Mohammed; Emma Craythorne; Ana M S Morley; Rongxuan Lim; Sally Turner; Tanya Henshaw; Isabel Garrood; Paola Giunti; Tammy Hedderly; Adesoji Abiona; Harsha Naik; Gemma Harrop; David McGibbon; Nicolaas G J Jaspers; Elena Botta; Tiziana Nardo; Miria Stefanini; Antony R Young; Robert P E Sarkany; Alan R Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.